雲南白藥(000538.SZ):雲南白藥牙膏依舊保持超過牙膏行業平均增長的態勢,實現市場份額25%
格隆匯10月19日丨雲南白藥(000538.SZ)在投資者互動平台表示,2023年上半年,健康品事業部實現主營業務收入32.45億元,同比增長0.81%,在口腔護理板塊及防脱洗護板塊均實現多項突破。在口腔護理板塊,雲南白藥牙膏依舊保持超過牙膏行業平均增長的態勢,實現市場份額25%(數據來源:尼爾森零售研究數據YTD2306),繼續保持行業市場份額第一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.